1. Proposed tariffs on Canadian pharmaceutical imports may significantly impact the U.S. drug supply chain, potentially leading to increased costs and shortages of vital medications.
2. About $3 billion worth of U.S. pharmaceuticals rely on Canadian manufacturing, and the proposed 25% tariffs could add $750 million in costs.
3. Health care providers are advised to closely monitor the drugs they depend on and anticipate potential shifts in the market and supply chains.
4. Certain medications, including antibiotics, pain medications, and antidepressants, could face supply disruptions due to the tariffs.
5. The study emphasizes the need for pharmaceuticals to be exempt from tariffs to avoid escalating healthcare costs and worsening disruptions in the U.S. supply.

Source: JAMA